Menu
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
We believe in personalized treatments tailored to your unique cancer and genes. Our tests are designed to pinpoint the most effective treatment options for your cancer journey!
Following your 30-minute value-packed consultation, our dedicated team curates the tests and therapies to support your cancer condition.
Through our comprehensive and personalized analysis, optimize your cancer journey. We are here to help you in the fight against cancer.
RGCC Followup tests monitor patients cancer at molecular level and its response to various treatments and help in early detection of cancer recurrence and relapse.
RGCC’s comprehensive tests are equipped to assess the sensitivity and determine the effectiveness of chemotherapeutic drugs and natural substances that are developed to fight the cancer.
RGCC’s advanced tests are designed to provide information on drug response, detect chromosomal abnormalities, assess the immune system, and anticipate cancer metastasis.
RGCC CAMBISeq®, using the next generation sequencing technique, the test offers a detailed insight into various cancers like Breast, Sarcoma, Melanoma, GI, etc. enabling to determine the most effective immunotherapies and treatments for those cancers.
RGCC Onco-D-clare detects cancer before the symptoms and enables individuals to take proactive measures towards their health.
RGCC has received prestigious recognition as one of the top 10 Swiss Biotech companies in 2023 by Life Sciences Review. Proudly standing alongside Switzerland’s esteemed biotech leaders, this acknowledgment underscores our unwavering commitment to innovation, excellence, and our continual contribution to the life sciences sector.
Every cancer is unique. So, individualized treatment is necessary to help patients win their battle against cancer. Through our steadfast commitment to cancer care and range of tests and therapies, we have improved outcomes for patients across the globe.
RGCC Testing provides valuable information about your cancer’s genetic profile, allowing our medical team to partner with your oncologist to design personalized treatment plans that target your specific cancer characteristics
The key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.
Director of RGCC, International GmbH
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our doctors to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
We provide comprehensive and personalized analysis that has helped countless patients in their battle against cancer. Using the tools and expertise from RGCC, we deliver precise results for personalized treatment decisions to enhance outcomes.
Integrative Oncologist
The comprehensive reports provided by RGCC not only benefit my practice of Integrative Oncology but also empower patients to embrace this holistic approach to cancer treatment, including modalities such as Mistletoe Therapy, hyperthermia, and more. The clear presentation of data in RGCC's reports helps patients feel empowered and engaged in their own care journey. RGCC's reports serve as a bridge between conventional oncology and Integrative Medicine, enabling patients to access a broader spectrum of treatment options that address not only the physical aspects of cancer but also its emotional, psychological, and spiritual dimensions.
Sr Integrative Oncologist
"With RGCC's Onconomics Extracts Plus test, I can assess the effectiveness of natural substances with precision, incorporating gene expression analysis for personalized treatment planning. This holistic approach enhances treatment outcomes and empowers patients to explore natural therapies tailored to their needs. A game-changer in integrative oncology."
Surgical Oncologist
"With tests like CAMBISeq, which identifies more than 500 oncogenes and helps determine that any changes in these oncogenes could lead to cancer. Now with these advanced tools like Next Generation Sequencing, we can pinpoint the exact gene and its mutation that is responsible for causing cancer. "
Medical Oncologist
My experience with RGCC was exceptional in a few cases, in many cases where I was confused about what treatment to offer, or when the patient wanted to know which treatment was more beneficial with minimal side effects, I have used RGCC. I used RGCC test, Onconomics Plus for my patient with pancreatic cancer recurrence and found sensitivity to various natural extracts so we proceeded with a treatment involving a cocktail of the extracts. We were able to postpone the chemotherapy for 6 months and improve the quality of life for that particular patient. I consider this a huge achievement and am thankful to RGCC for bringing the assays for clinical use.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
RGCC tests like Metastat accurately detect the development of secondary tumors.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
Indeed, tests are designed to reveal whether cancer cells are resistant or sensitivity to specific drugs and treatments.
If you’re looking for the right tools to navigate cancer with ease, RGCC tests are your solution. We offer cutting-edge diagnostics and personalized tests to combat your cancer and enhance the outcome of your treatment. With our expertise and dedication, we’re committed to making a meaningful difference in the fight against cancer.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
Copyright 2024 © All Right Reserved.
Designed by Bee High Media
